Sirfbio

Hyderabad, India Founded: 2014 • Age: 12 yrs
Automated nucleic acid extraction devices are developed for diagnostic applications.
Annual revenue $20,827 Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors - Known backers
Products - Services tracked
Competitors 11 Brand Intelligence

About Sirfbio

Sirfbio is a company based in Hyderabad (India) founded in 2014 by Shesheer Kumar. Sirfbio operates in a competitive market with competitors including Twist Bioscience, Nuclera Nucleics, Ansa Biotechnologies, Nutcracker Therapeutics and DNA Script, among others.

  • Headquarter Hyderabad, India
  • Founders Shesheer Kumar
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Sirf Bio Private Limited
  • Date of Incorporation 18 Dec, 2014
  • Jurisdiction Hyderabad, Telangana, India
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research Unlock Sub-Sector Unlock Segment
Healthcare → Biotechnology, Genomics & Life Sciences Research Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $20.83 K (USD)
    -67.12
    as on Mar 31, 2023
  • Net Profit
    -$28.77 K (USD)
    -464.48
    as on Mar 31, 2023
  • EBITDA
    -$27.01 K (USD)
    -388.16
    as on Mar 31, 2023
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Sirfbio

Premium access

Detailed funding history for Sirfbio

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Sirfbio

Investments
Premium access

Investment portfolio details for Sirfbio

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Sirfbio

Premium access

Detailed financials for Sirfbio

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Sirfbio Comparisons

Sirfbio Primary company
Description
Automated nucleic acid extraction devices are developed for ...
Location
Hyderabad, India
Founded Year
2014
Annual Revenue
$20.83 K (USD)
Net Profit
-$28.77 K (USD)
EBITDA
-$27.01 K (USD)
Employees
Not available
Premium access

Peer comparison for Sirfbio

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Sirfbio

Sirfbio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Twist Bioscience, Nuclera Nucleics, Ansa Biotechnologies, Nutcracker Therapeutics and DNA Script, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Synthetic DNA is synthesized via a semiconductor-based platform.
Locked Locked Locked
Desktop bioprinter for genes and proteins production is developed.
Locked Locked Locked
DNA synthesis technology using enzymes is provided.
Locked Locked Locked
mRNA therapeutics are developed via proprietary biochip platforms.
Locked Locked Locked
Benchtop DNA printers for nucleic acid synthesis are developed.
Locked Locked Locked
Developer of mRNA technology for therapeutics and vaccines
Premium access

Detailed competitors of Sirfbio

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Sirfbio

Premium access

Complete news archive for Sirfbio

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sirfbio

Sirfbio was founded in 2014.

Sirfbio is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.

Annual revenue of Sirfbio is $20.83K as on Mar 31, 2023.

Sirfbio was founded in 2014 in Hyderabad, India, within the biotechnology sector. Automated nucleic acid extraction devices are developed by the company, alongside an integrated real-time PCR system that handles isolation, amplification, and detection on one platform. DNA extraction processes are automated to produce reagents targeting infections such as malaria, tuberculosis, and leishmania. These solutions are designed for deployment in rural dispensaries across regions with limited infrastructure.

Sirfbio's top competitors include Nuclera Nucleics, Twist Bioscience and Ansa Biotechnologies.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available